Ultrasound-guided-fine-needle Aspiration Drainage and Percutaneous Ethanol Injection for Benign Neck Cysts.
Fine-needle aspiration
percutaneous ethanol injection
ultrasound
Journal
Journal of medical ultrasound
ISSN: 0929-6441
Titre abrégé: J Med Ultrasound
Pays: India
ID NLM: 9423829
Informations de publication
Date de publication:
Historique:
received:
22
11
2019
revised:
10
01
2020
accepted:
12
02
2020
entrez:
4
3
2021
pubmed:
5
3
2021
medline:
5
3
2021
Statut:
epublish
Résumé
Ultrasound-guided-fine-needle aspiration drainage (US-FNAD) and US-percutaneous ethanol injection (US-PEI) have been widely used in the management of benign neck cysts. However, the long-term results of US-FNAD and US-PEI are not well elucidated. We retrospectively collated patients under neck US examinations from March 2007 to December 2017 and investigated the recurrence after US-FNAD and US-PEI. Univariate and multivariate Cox regression analyses were used to assess significant risk factors for recurrence after US-FNAD. A total of 1075 patients were recruited, and their age was 50 ± 15 (mean ± standard deviation) years. A total of 862 patients had thyroid cysts, 118 patients had thyroglossal duct cysts (TGDC), twenty patients had branchial cleft cysts, 64 patients had parotid sialocysts, and 11 patients had plunging ranulas. Majority of the patients (97%, 1037/1075) reported significant symptom improvement immediately. However, 38% of the patients had recurrence with a median 3-year follow-up period. In a multivariate Cox regression analysis with adjustment for age and gender, plunging ranula (hazard ratio [HR]: 2.44, 95% confidence interval [CI]: 1.19-4.99) and lateral dimension size ≥ 0.8 cm (HR: 1.32, 95% CI: 1.04-1.67) after US-FNAD were independent risk factors for recurrence. There were 15 male and 19 female patients who received US-PEI therapy after repeated US-FNAD, of whom 23 patients had thyroid cysts, 6 had plunging ranulas, 4 had TGDC, and one had a branchial cleft cyst. The overall success rate was 94% (32/34), with a median follow-up period of 1.6 years. Two recurrent symptomatic patients had plunging ranulas. Some patients stated mild pain (21%, 7/34) and swelling sensation (26%, 9/34) after the injection. No major complications, such as vocal fold paresis or airway compression, were found. US-FNAD is an effective tool in the management of benign neck cysts with a 38% recurrence rate. Plunging ranulas have the highest rate of recurrence after FNAD. US-PEI is effective for most recurrent neck cysts after repeated US-FNAD.
Sections du résumé
BACKGROUND
BACKGROUND
Ultrasound-guided-fine-needle aspiration drainage (US-FNAD) and US-percutaneous ethanol injection (US-PEI) have been widely used in the management of benign neck cysts. However, the long-term results of US-FNAD and US-PEI are not well elucidated.
METHODS
METHODS
We retrospectively collated patients under neck US examinations from March 2007 to December 2017 and investigated the recurrence after US-FNAD and US-PEI. Univariate and multivariate Cox regression analyses were used to assess significant risk factors for recurrence after US-FNAD.
RESULTS
RESULTS
A total of 1075 patients were recruited, and their age was 50 ± 15 (mean ± standard deviation) years. A total of 862 patients had thyroid cysts, 118 patients had thyroglossal duct cysts (TGDC), twenty patients had branchial cleft cysts, 64 patients had parotid sialocysts, and 11 patients had plunging ranulas. Majority of the patients (97%, 1037/1075) reported significant symptom improvement immediately. However, 38% of the patients had recurrence with a median 3-year follow-up period. In a multivariate Cox regression analysis with adjustment for age and gender, plunging ranula (hazard ratio [HR]: 2.44, 95% confidence interval [CI]: 1.19-4.99) and lateral dimension size ≥ 0.8 cm (HR: 1.32, 95% CI: 1.04-1.67) after US-FNAD were independent risk factors for recurrence. There were 15 male and 19 female patients who received US-PEI therapy after repeated US-FNAD, of whom 23 patients had thyroid cysts, 6 had plunging ranulas, 4 had TGDC, and one had a branchial cleft cyst. The overall success rate was 94% (32/34), with a median follow-up period of 1.6 years. Two recurrent symptomatic patients had plunging ranulas. Some patients stated mild pain (21%, 7/34) and swelling sensation (26%, 9/34) after the injection. No major complications, such as vocal fold paresis or airway compression, were found.
CONCLUSION
CONCLUSIONS
US-FNAD is an effective tool in the management of benign neck cysts with a 38% recurrence rate. Plunging ranulas have the highest rate of recurrence after FNAD. US-PEI is effective for most recurrent neck cysts after repeated US-FNAD.
Identifiants
pubmed: 33659161
doi: 10.4103/JMU.JMU_111_19
pii: JMU-28-225
pmc: PMC7869730
doi:
Types de publication
Journal Article
Langues
eng
Pagination
225-229Informations de copyright
Copyright: © 2020 Journal of Medical Ultrasound.
Déclaration de conflit d'intérêts
There are no conflicts of interest.
Références
J Clin Endocrinol Metab. 1998 Mar;83(3):830-5
pubmed: 9506736
Int J Hyperthermia. 2019;36(1):376-382
pubmed: 30909759
Thyroid. 1999 Mar;9(3):225-33
pubmed: 10211597
AJNR Am J Neuroradiol. 2017 Dec;38(12):2351-2356
pubmed: 28970243
Ann Otol Rhinol Laryngol. 2015 Jan;124(1):62-7
pubmed: 25048959
Acta Otolaryngol. 2004 Dec;124(10):1226-30
pubmed: 15768823
Mayo Clin Proc. 2018 Aug;93(8):1009-1017
pubmed: 30078409
Acta Med Croatica. 2009 Dec;63 Suppl 3:21-7
pubmed: 20235370
Clin Otolaryngol. 2019 May;44(3):286-292
pubmed: 30636109
Endocr Pract. 2018 Jun;24(6):548-555
pubmed: 29624094
Curr Opin Endocrinol Diabetes Obes. 2016 Oct;23(5):400-6
pubmed: 27504993
Head Neck. 2011 Nov;33(11):1649-55
pubmed: 20737487
AJNR Am J Neuroradiol. 2011 Feb;32(2):306-9
pubmed: 21087937
Clin Endocrinol (Oxf). 2017 Dec;87(6):639-648
pubmed: 28718950
Ann Plast Surg. 1994 Dec;33(6):615-9
pubmed: 7880052
Laryngoscope. 2017 Oct;127(10):2239-2241
pubmed: 28407263
J Thyroid Res. 2017;2017:9536479
pubmed: 28775909
Best Pract Res Clin Endocrinol Metab. 2014 Aug;28(4):601-18
pubmed: 25047209
Cochrane Database Syst Rev. 2014 Jun 18;(6):CD004098
pubmed: 24941398
Indian J Radiol Imaging. 2012 Oct;22(4):334-43
pubmed: 23833426
Thyroid. 2016 Jan;26(1):1-133
pubmed: 26462967